Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Judit Marsillach

Showing results (41-50 of 75) with videos related to

Pageof 8
Sort By:
Journal of Hepatology|March 3, 2006
Paraoxonase-1 is associated with oxidative stress, fibrosis and FAS expression in chronic liver diseasesNatàlia Ferré, Judit Marsillach, Jordi Camps, et al.
Medrxiv : the Preprint Server for Health Sciences|May 2, 2025
Investigating biomarkers of exposure to jet aircraft oil fumes using mass spectrometryClement E Furlong, Rebecca Richter, Judit Marsillach, et al.
Clinical Chemistry|April 6, 2006
Influence of PON1 polymorphisms on the association between serum paraoxonase 1 and homocysteinemia in a general populationMichelle M Murphy, Judit Marsillach, Jordi Camps, et al.
Clinical Biochemistry|October 26, 2005
The role of circulating monocyte chemoattractant protein-1 as a marker of hepatic inflammation in patients with chronic liver diseaseJudit Marsillach, Núria Bertran, Jordi Camps, et al.
Neurotoxicology and Teratology|July 3, 2021
Paraoxonase 2 deficiency in mice alters motor behavior and causes region-specific transcript changes in the brainJacqueline M Garrick, Toby B Cole, Theo K Bammler, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|October 3, 2009
Increased PAFAH and oxidized lipids are associated with inflammation and atherosclerosis in hypercholesterolemic pigsDieuwke De Keyzer, Sonia-Athina Karabina, Wenhzong Wei, et al.
Clinical Biochemistry|November 4, 2008
The measurement of the lactonase activity of paraoxonase-1 in the clinical evaluation of patients with chronic liver impairmentJudit Marsillach, Gerard Aragonès, Raul Beltrán, et al.
Disease Markers|March 21, 2022
Paraoxonase-1 (PON-1) Arylesterase Activity Levels in Patients with Coronary Artery Disease: A Meta-AnalysisMarco Zuin, Alessandro Trentini, Judit Marsillach, et al.
Chemico-Biological Interactions|April 12, 2016
Developmental expression of paraoxonase 2Jacqueline M Garrick, Khoi Dao, Rian de Laat, et al.
Mediators of Inflammation|June 15, 2013
Paraoxonase-1 inhibits oxidized low-density lipoprotein-induced metabolic alterations and apoptosis in endothelial cells: a nondirected metabolomic studyAnabel García-Heredia, Judit Marsillach, Anna Rull, et al.
Pageof 8

Showing results (41-50 of 75) with videos related to

Sort By:
Pageof 8
Journal of Hepatology|March 3, 2006
Paraoxonase-1 is associated with oxidative stress, fibrosis and FAS expression in chronic liver diseasesNatàlia Ferré, Judit Marsillach, Jordi Camps, et al.
Medrxiv : the Preprint Server for Health Sciences|May 2, 2025
Investigating biomarkers of exposure to jet aircraft oil fumes using mass spectrometryClement E Furlong, Rebecca Richter, Judit Marsillach, et al.
Clinical Chemistry|April 6, 2006
Influence of PON1 polymorphisms on the association between serum paraoxonase 1 and homocysteinemia in a general populationMichelle M Murphy, Judit Marsillach, Jordi Camps, et al.
Clinical Biochemistry|October 26, 2005
The role of circulating monocyte chemoattractant protein-1 as a marker of hepatic inflammation in patients with chronic liver diseaseJudit Marsillach, Núria Bertran, Jordi Camps, et al.
Neurotoxicology and Teratology|July 3, 2021
Paraoxonase 2 deficiency in mice alters motor behavior and causes region-specific transcript changes in the brainJacqueline M Garrick, Toby B Cole, Theo K Bammler, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|October 3, 2009
Increased PAFAH and oxidized lipids are associated with inflammation and atherosclerosis in hypercholesterolemic pigsDieuwke De Keyzer, Sonia-Athina Karabina, Wenhzong Wei, et al.
Clinical Biochemistry|November 4, 2008
The measurement of the lactonase activity of paraoxonase-1 in the clinical evaluation of patients with chronic liver impairmentJudit Marsillach, Gerard Aragonès, Raul Beltrán, et al.
Disease Markers|March 21, 2022
Paraoxonase-1 (PON-1) Arylesterase Activity Levels in Patients with Coronary Artery Disease: A Meta-AnalysisMarco Zuin, Alessandro Trentini, Judit Marsillach, et al.
Chemico-Biological Interactions|April 12, 2016
Developmental expression of paraoxonase 2Jacqueline M Garrick, Khoi Dao, Rian de Laat, et al.
Mediators of Inflammation|June 15, 2013
Paraoxonase-1 inhibits oxidized low-density lipoprotein-induced metabolic alterations and apoptosis in endothelial cells: a nondirected metabolomic studyAnabel García-Heredia, Judit Marsillach, Anna Rull, et al.
Pageof 8